The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Osteoporosis

Interventions

DRUG

risedronate (including placebo)

risedronate 35mg weekly

Trial Locations (1)

University of Pittsburgh Medical Center (GCRC), Pittsburgh